Open Access
| Issue |
BIO Web Conf.
Volume 214, 2026
The 2025 International Conference on Biomedical, Bioinformatics and Statistics (ICBBS 2025)
|
|
|---|---|---|
| Article Number | 01019 | |
| Number of page(s) | 5 | |
| Section | Biomedical, Bioinformatics and Statistics | |
| DOI | https://doi.org/10.1051/bioconf/202621401019 | |
| Published online | 02 February 2026 | |
- E. F. McCarthy, The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthopaedic Journal 26, 154–158 (2006). [Google Scholar]
- M. Tufail, C. H. Jiang, N. Li, Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduction and Targeted Therapy 10, 227 (2025). [Google Scholar]
- S. Ahuja, S. Zaheer, The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives. Korean Journal of Clinical Oncology 20, 51–73 (2024). [Google Scholar]
- D. Ribatti, The concept of immune surveillance against tumors: the first theories. Oncotarget 8, 7175–7180 (2017). [Google Scholar]
- J. B. Swann, M. J. Smyth, Immune surveillance of tumors. Journal of Clinical Investigation 117, 1137–1146 (2007). [Google Scholar]
- G. P. Dunn, L. J. Old, R. D. Schreiber, The three Es of cancer immunoediting. Annual Review of Immunology 22, 329–360 (2004). [Google Scholar]
- D. M. Pardoll, The blockade of immune checkpoints in cancer immunotherapy. Nature Reviews Cancer 12, 252–264 (2012). [CrossRef] [PubMed] [Google Scholar]
- J. Wang, Y. He, F. Hu, C. Hu, Y. Sun, K. Yang, S. Yang, Metabolic reprogramming of immune cells in the tumor microenvironment. International Journal of Molecular Sciences 25, 12223 (2024). [Google Scholar]
- H. Jing, Y. Gao, Z. Sun, S. Liu, Recent advances in novel tumor immunotherapy strategies based on regulating the tumor microenvironment and immune checkpoints. Frontiers in Immunology 16, 1529403 (2025). [Google Scholar]
- K. Park, M. S. Veena, D. S. Shin, Key players of the immunosuppressive tumor microenvironment and emerging therapeutic strategies. Frontiers in Cell and Developmental Biology 10, 830208 (2022). [Google Scholar]
- M. Kciuk, E. B. Yahya, M. Mohamed Ibrahim Mohamed, S. Rashid, M. O. Iqbal, R. Kontek, M. A. Abdulsamad, A. A. Allaq, Recent advances in molecular mechanisms of cancer immunotherapy. Cancers 15, 2721 (2023). [Google Scholar]
- Y. Shiravand, F. Khodadadi, S. M. A. Kashani, S. R. Hosseini-Fard, S. Hosseini, H. Sadeghirad, R. Ladwa, K. O'Byrne, A. Kulasinghe, Immune checkpoint inhibitors in cancer therapy. Current Oncology 29, 3044–3060 (2022). [Google Scholar]
- T. Zhao, J. You, C. Wang, B. Li, Y. Liu, M. Shao, W. Zhao, C. Zhou, Cell-based immunotherapies for solid tumors: advances, challenges, and future directions. Frontiers in Oncology 15, 1551583 (2025). [Google Scholar]
- M. Kaczmarek, J. Poznahska, F. Fechner, N. Michalska, S. Paszkowska, A. Napierala, A. Mackiewicz, Cancer vaccine therapeutics: limitations and effectiveness—A literature review. Cells 12, 2159 (2023). [Google Scholar]
- M. Matsushita, M. Kawaguchi, Immunomodulatory effects of drugs for effective cancer immunotherapy. Journal of Oncology 2018, 8653489 (2018) 9 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.